CTOs on the Move


 
Moki enables digital interactions in physical environments with its leading mobile software platform. The company was founded in 2012 and has enabled 150,000 devices for digital interactions in physical environments. Moki's platform provides management, analysis, and security to its customers.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.moki.com
  • 2600 Executive Parkway Suite 300
    Lehi, UT USA 84043
  • Phone: 888.329.8942

Executives

Name Title Contact Details

Similar Companies

Digital Signal

Digital Signal Corporation engages in the research and development of three-dimensional facial recognition systems for the department of defense and other federal agencies. The company was founded in 2001 and is based in Alexandria, Virginia.

Reflexis Systems

Reflexis maintains an unmatched 100% track record of on-time, within-budget deployments, and service levels unequaled in the software industry.

Computac

Computac is a West Lebanon, NH-based company in the Software and Internet sector.

CareVoyant

CareVoyant is a Schaumburg, IL-based company in the Software and Internet sector.

Castor

Castor is a leading provider of clinical trial technology that automates the research process. Castor is helping Democratize Clinical Research and making DCTs scalable with EDC, eConsent, ePRO & eCOA + DCT integrations. These solutions enable researchers to easily capture and integrate data from any source and decentralize their trials. Highlights: -Build studies within hours leveraging pre-built templates -Integrate EMR/EHR, patient, clinician, device, and wearable data -90% of studies in Castor are built and pass UAT in less than 4 weeks, significantly faster than the industry benchmark More than 40,000 researchers across 90 countries are using Castor to supercharge their research. Castor`s platform has supported more than 8,500 studies that cover a broad range of disease areas including diabetes, cardiovascular disease, central nervous system (CNS), rare diseases, infectious diseases, and oncology.